Skip to main content
Premium Trial:

Request an Annual Quote

Chinese Firm Builds Genomics Facility for Translational Research with PacBio as Major Platform


NEW YORK (GenomeWeb) − The Suqian Lakeside Pangu Gene Company in Tianjin, China, has established a new genomics facility for translational medicine research projects.

The company plans to focus on molecular-based approaches for the early diagnosis of cancer and disease recurrence, and on drug efficacy evaluation.

The new facility, located in the Tianjin Dong Li Lake Technology Park, has 1,500 square meters of lab space and will be using Pacific Biosciences' PacBio RS II as its major sequencing platform, the two firms said this week. Earlier this year, SLPC purchased four PacBio RS II systems, which were recently installed.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.